Global POC Testing Market to Reach USD 30 Billion by 2022
The global Point-of-Care (POC) testing market is
projected to reach USD 30 billion by 2022, driven by the immense potential of
POC tests to improve global health and eventually reduce public and national
spending on health.
These are the latest findings of Research and Markets,
(Dublin, Ireland), a global market research company.
POC testing devices have now found applications in a large
number of medical conditions and their increased usage in the field of critical
care settings for delivering decentralized, patient-centric healthcare to
patients is expected to drive a rapid growth in the POC testing market.
Increasing awareness about POCT, technological advancements and increasing FDA
approvals are the major drivers of the global POC testing market. However, some
challenges, such as product recalls and lack of regulatory standards, are
hindering market growth.
On the basis of type of product, glucose monitoring kits
accounted for the largest market share in 2017 due to the rising prevalsence of
diabetes & technological advancements in self-monitoring of blood glucose.
Based on geography, North America accounted for the largest share of the global
POC testing market in 2017.
